Table 3. The pathways involved in ING5 overexpression in SGC-7901 cells.
| Num | Pathway | Diff Proteins | All Proteins | p value |
|---|---|---|---|---|
| 1 | Osteoclast differentiation | 3 (11.11%) | 22 (1.08%) | 0.0027207 |
| 2 | Phagosome | 4 (14.81%) | 52 (2.56%) | 0.0043232 |
| 3 | Cell adhesion molecules (CAMs) | 2 (7.41%) | 10 (0.49%) | 0.0071602 |
| 4 | Amyotrophic lateral sclerosis (ALS) | 2 (7.41%) | 14 (0.69%) | 0.0140131 |
| 5 | ECM-receptor interaction | 2 (7.41%) | 15 (0.74%) | 0.0160374 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 1 (3.7%) | 3 (0.15%) | 0.0393349 |
| 7 | Vitamin digestion and absorption | 1 (3.7%) | 3 (0.15%) | 0.0393349 |
| 8 | Malaria | 1 (3.7%) | 3 (0.15%) | 0.0393349 |
| 9 | Autoimmune thyroid disease | 1 (3.7%) | 3 (0.15%) | 0.0393349 |
| 10 | Graft-versus-host disease | 1 (3.7%) | 3 (0.15%) | 0.0393349 |
| 11 | Allograft rejection | 1 (3.7%) | 3 (0.15%) | 0.0393349 |
| 12 | Peroxisome | 2 (7.41%) | 27 (1.33%) | 0.0486255 |